Martin Schlegel

7PUBLICATIONS
26CO-AUTHORS
Biologically active moleculesPredictive and prognostic markersInfectious diseasesBiomaterialsBioprocessing, bioproduction and bioproducts
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 14, 2025
GAL-201 as a Promising Amyloid-β-Targeting Small-Molecule Approach for Alzheimer's Disease Treatment: Consistent Effects on Synaptic Plasticity, Behavior and Neuroinflammation.

Katrin Riemann, Jeldrik von Ahsen, Tamara Böhm

|Dec 23, 2023
Biomarkers in Adult-Type Diffuse Gliomas: Elevated Levels of Circulating Vesicular Heat Shock Protein 70 Serve as a Biomarker in Grade 4 Glioblastoma and Increase NK Cell Frequencies in Grade 3 Glioma.

Philipp Lennartz, Dennis Thölke, Ali Bashiri Dezfouli

|Nov 07, 2023
Platelet aggregates detected using quantitative phase imaging associate with COVID-19 severity.

Christian Klenk, Johanna Erber, David Fresacher

|Oct 27, 2023
Chronic administration of XBD173 ameliorates cognitive deficits and neuropathology via 18 kDa translocator protein (TSPO) in a mouse model of Alzheimer's disease.

Arpit Kumar Pradhan, Tatjana Neumüller, Claudia Klug

|Jun 24, 2022
Beta-Site Amyloid Precursor Protein-Cleaving Enzyme Inhibition Partly Restores Sevoflurane-Induced Deficits on Synaptic Plasticity and Spine Loss.

Xingxing Wang, Qinfang Shi, Arpit Kumar Pradhan

|Jan 11, 2022
Netrin-1: A Modulator of Macrophage Driven Acute and Chronic Inflammation.

Laura Ziegon, Martin Schlegel

Pageof 2

Frequent Collaborators

2 joint publications

Arpit Kumar Pradhan

1 joint publications

Tessa J Barrett

1 joint publications

Felix Zhou

1 joint publications

Mike Gorenchtein